Insulin signaling pathway components

The insulin signaling pathway is a complex intracellular cascade essential for maintaining glucose homeostasis and regulating lipid and protein metabolism [antibodies.com, cellsignal.com]. It is initiated by insulin binding to the insulin receptor (INSR), a heterotetrameric receptor tyrosine kinase, which undergoes autophosphorylation and recruits insulin receptor substrate (IRS) proteins [wikipedia.org, nih.gov]. These substrates activate two major downstream branches: the PI3K/AKT pathway, which mediates metabolic actions such as GLUT4 translocation for glucose uptake, and the Ras/MAPK pathway, which regulates cell growth and proliferation [mdpi.com, creative-diagnostics.com]. Dysfunctions in this pathway, such as insulin resistance or receptor downregulation, are central to the pathogenesis of type 2 diabetes, obesity, and metabolic syndrome [nih.gov, mdpi.com]. Furthermore, over-activation of the pathway is frequently observed in various cancers, making components like PI3K and AKT attractive targets for oncology therapeutics [mdpi.com, researchgate.net]. Pharmacological modulation includes insulin analogs for replacement therapy, sensitizers like metformin and thiazolidinediones, and targeted inhibitors for cancer treatment [researchgate.net, nih.gov].

Other names

Insulin signal transduction pathwayInsulin receptor signaling pathwayIIS pathwayInsulin signaling cascade

Activation of the insulin receptor triggers a phosphorylation cascade involving IRS, PI3K, and AKT, leading to glucose transporter translocation and metabolic regulation.